These Evi1-transgenic mice developed a disease resembling myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN), characterized by anemia and thrombocytopenia, accompanied by an expansion of myelopoiesis and suppressed lymphopoiesis. The gene discussed is MECOM; the disease is anemia.